Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stéphane Bancel
Biotech
FDA appears less prickly toward Moderna mRNA flu shot
Briefing documents released by the FDA Tuesday appear to bode well for Moderna's chances ahead of an upcoming advisory committee grilling.
Fraiser Kansteiner
Jun 16, 2026 2:46pm
Fierce Pharma
Vaccine makers facing increased volatility, uncertainty at FDA
Feb 13, 2026 11:12am
Moderna sprints toward RSV podium behind GSK, Pfizer
Jan 4, 2023 3:37pm
Moderna CEO: Mpox vaccine development is not a high priority
Jan 4, 2023 9:49am
Moderna's Bancel has 'never been as busy' amid M&A talks
May 4, 2022 11:19am
Moderna's CMO Zaks quits for 'next leg of his career'
Feb 25, 2021 7:23am
